Cdk5 modulation of mitogen-activated protein kinase signaling regulates neuronal survival

Molecular Biology of the Cell

Volumn 18, Issue 2, 2007, Pages 404-413

  Zheng, Ya Li ^a   Li, Bing Sheng ^a   Kanungo, Jyotshna ^a   Kesavapany, Sashi ^a   Amin, Niranjana ^a   Grant, Philip ^a   Pant, Harish C ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 5; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; NERVE GROWTH FACTOR; PD 98095; ROSCOVITINE; SMALL INTERFERING RNA; TAU PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN NERVE CELL; CELL SURVIVAL; CONTROLLED STUDY; DRUG MECHANISM; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME KINETICS; ENZYME PHOSPHORYLATION; ENZYME REGULATION; NERVE FIBER; NEUROFILAMENT; NONHUMAN; PERIKARYON; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; REGULATORY MECHANISM; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL SURVIVAL; CEREBRAL CORTEX; CYCLIN-DEPENDENT KINASE 5; CYTOSKELETAL PROTEINS; MAP KINASE KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NEURONS; PC12 CELLS; PHOSPHORYLATION; PURINES; RATS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 33846828462     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E06-09-0851     Document Type: Article

References (48)

1. Alessandrini, A., Brott, B. K., and Erikson, R. L. (1997). Differential expression of MEK1 and MEK2 during mouse development. Cell Growth Differ. 8, 505-511.
2. Buee, L., Bussiere, T., Buee-Scherrer, V., Delacourte, A., and Hof, P. R. (2000). Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Brain Res. Rev. 33, 95-130.
3. Cheung, E. C., and Slack, R. S. (2004). Emerging role for ERK as a key regulator of neuronal apoptosis. Sci. STKE 2004, PE45.
4. Cheung, Z. H., and Ip, N. Y. (2004). Cdk 5, mediator of neuronal death and survival. Neurosci. Lett. 361, 47-51.
5. Cheung, Z. H., Fu, A. K., and Ip, N. Y. (2006). Synaptic roles of Cdk5: implications in higher cognitive functions and neurodegenerative diseases. Neuron 50, 13-18.
6. Cruz, J. C., and Tsai, L. H. (2004). A Jekyll and Hyde kinase: roles for Cdk5 in brain development and disease. Curr. Opin. Neurobiol. 14, 390-394.
7. Dhavan, R., and Tsai, L. H. (2001). A decade of CDK5. Nat. Rev. Mol. Cell Biol. 2, 749-759.
8. Goslin, K., Asmussen, H., and Branker, G. (1998). Culturing Nerve Cells, Cambridge, MA: MIT Press.
9. Gupta, A., and Tsai, L. H. (2003). Cyclin-dependent kinase 5 and neuronal migration in the neocortex. Neurosignals 12, 173-179.
10. Hallows, J. L., Chen, K., DePinho, R. A., and Vincent, I. (2003). Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice. J. Neurosci. 23, 10633-10644.
11. Harada, T., Morooka, T., Ogawa, S., and Nishida, E. (2001). ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1. Nat. Cell Biol. 3, 453-459.
12. Heasley, L. E., and Johnson, G. L. (1992). The β-PDGF receptor induces neuronal differentiation of PC12 cells. Mol. Biol. Cell 3, 545-553.
13. Irving, E. A., and Bamford, M. (2002). Role of mitogen- and stress-activated kinases in ischemic injury. J. Cereb. Blood Flow and Metab. 22, 631-647.
14. Kesavapany, S., et al. (2004). p35/Cyclin-dependent kinase 5 phosphorylation of ras guanine nucleotide releasing factor 2 (RasGRF2) mediates Rac-dependent extracellular signal-regulated kinase 1/2 activity, altering RasGRF2 and microtubule-associated protein 1b distribution in neurons. J. Neurosci. 24, 4421-4431.
15. Kesavapany, S., Li, B. S., and Pant, H. C. (2003). Cyclin-dependent kinase 5 in neurofilament function and regulation. Neurosignals 12, 252-264.
16. Keyse, S. M. (2000). Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr. Opin. Cell Biol. 12, 186-192.
17. Lee, M. S., Kwon, Y. T., Li, M., Peng, J., Friedlander, R. M., and Tsai, L. H. (2000). Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405, 360-364.
18. Li, B. S., Ma, W., Jaffe, H., Zheng, Y., Takahashi, S., Zhang, L., Kulkarni, A. B., and Pant, H. C. (2003). Cyclin-dependent kinase-5 is involved in neuregulin-dependent activation of phosphatidylinositol 3-kinase and Akt activity mediating neuronal survival. J. Biol. Chem. 278, 35702-35709.
19. Li, B. S., Zhang, L., Takahashi, S., Ma, W., Jaffe, H., Kulkarni, A. B., and Pant, H. C. (2002). Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3. EMBO J. 21, 324-333.
20. Marshall, C. J. (1995). Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80, 179-185.
21. Miller, F. D., and Kaplan, D. R. (2001). Neurotrophin signalling pathways regulating neuronal apoptosis. Cell Mol. Life Sci. 58, 1045-1053.
22. Monaco, E. A., and Vallano, M. L. (2005). Roscovitine triggers excitotoxicity in cultured granule neurons by enhancing glutamate release. Mol. Pharmacol. 68, 1331-1342.
23. Morfini, G., Szebenyi, G., Brown, H., Pant, H. C., Pigino, G., DeBoer, S., Beffert, U., and Brady, S. T. (2004). A novel CDK-5 dependent pathway for regulating GSK3 activity and kinesin-driven motility in neurons. EMBO J. 23, 2235-2245.
24. Morishima-Kawashima, M., and Kosik, K. S. (1996). The pool of map kinase associated with microtubules is small but constitutively active. Mol. Biol. Cell 7, 893-905.
25. Nasevicius, A., and Ekker, S. C. (2000). Effective targeted gene 'knockdown' in zebrafish. Nat. Genet. 26, 216-220.
26. Nikolic, M., Dudek, H., Kwon, Y. T., Ramos, Y. F., and Tsai, L. H. (1996). The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev. 10, 816-825.
27. Ohshima, T., Ward, J. M., Huh, C. G., Longenecker, G., Veeranna, Pant, H. C., Brady, R. O., Martin, L. J., and Kulkarni, A. B. (1996). Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc. Natl. Acad. Sci. USA 93, 11173-11178.
28. Patrick, G. N., Zukerberg, L., Nikolic, M., de la Monte, S., Dikkes, P., and Tsai, L. H. (1999). Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402, 615-622.
29. Plattner, F., Angelo, M., and Giese, K. P. (2006). The roles of cyclin-dependent kinase 5 and glycogen synthase 3 in tau hyperphosphorylation. J. Biol. Chem. 281, 25457-25465.
30. Pouyssegur, J., and Lenormand, P. (2003). Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling. Eur. J. Biochem. 270, 3291-3299.
31. Reszka, A. A., Seger, R., Diltz, C. D., Krebs, E. G., and Fischer, E. H. (1995). Association of mitogen-activated protein kinase with the microtubule cytoskeleton. Proc. Natl. Acad. Sci. USA 92, 8881-8885.
32. Reynolds, C. H., Betts, J. C., Blackstock, W. P., Nebreda, A. R., and Anderton, B. H. (2000). Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta. J. Neurochem. 74, 1587-1595.
33. Sharma, P., Veeranna, Sharma, M., Amin, N. D., Sihag, R. K., Grant, P., Ahn, N., Kulkarni, A. B., and Pant, H. C. (2002). Phosphorylation of MEK1 by cdk5/p35 down-regulates the mitogen-activated protein kinase pathway. J. Biol. Chem. 277, 528-534.
34. Smith, D. S., and Tsai, L. H. (2002). Cdk5 behind the wheel: a role in trafficking and transport? Trends Cell Biol. 12, 28-36.
35. Stanciu, M., et al. (2000). Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J. Biol. Chem. 275, 12200-12206.
36. Stork, P. J. (2002). ERK signaling: duration, duration, duration. Cell Cycle 1, 315-317.
37. Subramaniam, S., Strelau, J., and Unsicker, K. (2003). Growth differentiation factor-15 prevents low potassium-induced cell death of cerebellar granule neurons by differential regulation of Akt and ERK pathways. J. Biol. Chem. 278, 8904-8912.
38. Subramaniam, S., Zirrgiebel, U., von Bohlen Und Halbach, O., Strelau, J., Laliberte, C., Kaplan, D. R., and Unsicker, K. (2004). ERK activation promotes neuronal degeneration predominantly through plasma membrane damage and independently of caspase-3. J. Cell Biol. 165, 357-369.
39. Tanaka, T., Veeranna, Ohshima, T., Rajan, P., Amin, N. D., Cho, A., Sreenath, T., Pant, H. C., Brady, R. O., and Kulkarni, A. B. (2001). Neuronal cyclin-dependent kinase 5 activity is critical for survival. J. Neurosci. 21, 550-558.
40. Tomizawa, K., Ohta, J., Matsushita, M., Moriwaki, A., Li, S.-T., Takei, K., and Matsui, H. (2002). Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity. J. Neurosci. 22, 2590-2597.
41. Traverse, S., Gomez, N., Paterson, H., Marshall, C., and Cohen, P. (1992). Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem. J. 288, 351-355.
42. Veeranna, Amin, N. D., Ahn, N. G., Jaffe, H., Winters, C. A., Grant, P., and Pant, H. C. (1998). Mitogen-activated protein kinases (Erk1,2) phosphorylate Lys-Ser-Pro (KSP) repeats in neurofilament proteins NF-H and NF-M. J. Neurosci. 18, 4008-4021.
43. Veeranna, Shetty, K. T., Takahashi, M., Grant, P., and Pant, H. C. (2000). Cdk5 and MAPK are associated with complexes of cytoskeletal proteins in rat brain. Brain Res. Mol. Brain Res. 76, 229-236.
44. Zhang, B. F., Peng, F. F., Zhang, W., Shen, H., Wu, S. B., and Wu, D. C. (2004). Involvement of cyclin dependent kinase 5 and its activator p35 in staurosporine-induced apoptosis of cortical neurons. Acta Pharmacol. Sin. 25, 1105-1111.
45. Zhang, J., and Johnson, G. V. (2000). Tau protein is hyperphosphorylated in a site-specific manner in apoptotic neuronal PC12 cells. J. Neurochem. 75, 2346-2357.
46. Zheng, Y. L., Kesavapany, S., Gravell, M., Hamilton, R. S., Schubert, M., Amin, N., Albers, W., Grant, P., and Pant, H. C. (2004). A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons. EMBO J. 24, 209-220.
47. Zheng, Y. L., Li, B. S., Amin, N. D., Albers, W., and Pant, H. C. (2002). A peptide derived from cyclin-dependent kinase activator (p35) specifically inhibits Cdk5 activity and phosphorylation of tau protein in transfected cells. Eur. J. Biochem. 269, 4427-4434.
48. Zheng, Y. L., Li, B. S., Veeranna, and Pant, H. C. (2003). Phosphorylation of the head domain of neurofilament protein (NF-M): a factor regulating topographic phosphorylation of NF-M tail domain KSP sites in neurons. J. Biol. Chem. 278, 24026-24032.